Long-term administration of cocaine or serotonin reuptake inhibitors results in anatomical and neurochemical changes in noradrenergic, dopaminergic, and serotonin pathways

Journal of Neurochemistry

Volumn 106, Issue 4, 2008, Pages 1731-1744

  Horne, Malcolm K ^a,b   Lee, Joohyung ^b   Chen, Feng ^b   Lanning, Katherine ^b   Tomas, Doris ^b   Lawrence, Andrew J ^b  

^a FLOREY INSTITUTE OF NEUROSCIENCE AND MENTAL HEALTH   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Addiction; Catecholamine; Depression; Indolamine; Plasticity; Transporter

Indexed keywords

AUTORECEPTOR; CATECHOL; COCAINE; DOPAMINE; FLUOXETINE; INDOLE; SEROTONIN; SEROTONIN 1A RECEPTOR; SEROTONIN UPTAKE INHIBITOR;

ANATOMY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ATTENUATION; COMPARATIVE STUDY; CONTROLLED STUDY; CORPUS STRIATUM; DENSITY; DOPAMINE RELEASE; DOPAMINERGIC SYSTEM; DORSAL RAPHE NUCLEUS; FRONTAL CORTEX; LOCUS CERULEUS; MALE; MESENCEPHALON; MORPHOLOGY; NERVE CELL PLASTICITY; NEUROCHEMISTRY; NONHUMAN; NORADRENERGIC NERVE; NORADRENERGIC SYSTEM; OLFACTORY BULB; PRIORITY JOURNAL; RAT; SEPTUM NUCLEUS; SEROTONINERGIC SYSTEM;

ANIMALS; BRAIN CHEMISTRY; COCAINE; DOPAMINE; MALE; NOREPINEPHRINE; RATS; RATS, WISTAR; SEROTONIN; SEROTONIN UPTAKE INHIBITORS; SIGNAL TRANSDUCTION; TIME;

ANIMALIA; RATTUS;

EID: 48749121466     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2008.05534.x     Document Type: Article

References (72)

1. Albert P. R. Tiberi M. (2001) Receptor signaling and structure: insights from serotonin-1 receptors. Trends Endocrinol. Metab. 12, 453 460.
2. Balu D. T., Hoshaw B. A., Malberg J. E., Rosenzweig-Lipson S., Schechter L. E. Lucki I. (2008) Differential regulation of central BDNF protein levels by antidepressant and non-antidepressant drug treatments. Brain Res. 1211, 37 43.
3. Beique J. C., Lavoie N., de Montigny C. Debonnel G. (1998) Affinities of venlafaxine and various reuptake inhibitors for the serotonin and norepinephrine transporters. Eur. J. Pharmacol. 349, 129 132.
4. Benmansour S., Altamirano A. V., Jones D. J., Sanchez T. A., Gould G. G., Pardon M. C., Morilak D. A. Frazer A. (2004) Regulation of the norepinephrine transporter by chronic administration of antidepressants. Biol. Psychiatry 55, 313 316.
5. Benveniste E. N., Sparacio S. M., Norris J. G., Grenett H. E. Fuller G. M. (1990) Induction and regulation of interleukin-6 gene expression in rat astrocytes. J. Neuroimmunol. 30, 201 212.
6. Bjorklund A., Rosenblad C., Winkler C. Kirik D. (1997) Studies on neuroprotective and regenerative effects of GDNF in a partial lesion model of Parkinson's disease. Neurobiol. Dis. 4, 186 200.
7. Bowenkamp K. E., David D., Lapchak P. L., Henry M. A., Granholm A. C., Hoffer B. J. Mahalik T. J. (1996) 6-Hydroxydopamine induces the loss of the dopaminergic phenotype in substantia nigra neurons of the rat. A possible mechanism for restoration of the nigrostriatal circuit mediated by glial cell line-derived neurotrophic factor. Exp. Brain Res. 111, 1 7.
8. 2+-evoked release of [3H]dopamine from striatal synaptosomes by dopamine (D2) agonists and antagonists. J. Pharmacol. Exp. Ther. 241, 27 33.
9. Bunney B. S., Aghajanian G. K. Roth R. H. (1973) Comparison of effects of L-dopa, amphetamine and apomorphine on firing rate of rat dopaminergic neurones. Nat. New Biol. 245, 123 125.
10. Bymaster F. P., Zhang W., Carter P. A., Shaw J., Chernet E., Phebus L., Wong D. T. Perry K. W. (2002) Fluoxetine, but not other selective serotonin uptake inhibitors, increases norepinephrine and dopamine extracellular levels in prefrontal cortex. Psychopharmacology (Berl.) 160, 353 361.
11. Calabresi P., Pisani A., Mercuri N. B. Bernardi G. (1996) The corticostriatal projection: from synaptic plasticity to dysfunctions of the basal ganglia. Trends Neurosci. 19, 19 24.
12. Calabresi P., Saiardi A., Pisani A., Baik J. H., Centonze D., Mercuri N. B., Bernardi G. Borrelli E. (1997) Abnormal synaptic plasticity in the striatum of mice lacking dopamine D2 receptors. J. Neurosci. 17, 4536 4544.
13. Castro E., Tordera R. M., Hughes Z. A., Pei Q. Sharp T. (2003) Use of Arc expression as a molecular marker of increased postsynaptic 5-HT function after SSRI/5-HT1A receptor antagonist co-administration. J. Neurochem. 85, 1480 1487.
14. Centonze D., Picconi B., Gubellini P., Bernardi G. Calabresi P. (2001) Dopaminergic control of synaptic plasticity in the dorsal striatum. Eur. J. Neurosci. 13, 1071 1077.
15. Chen F. Lawrence A. J. (2004) Chronic antidepressant treatment causes a selective reduction of mu-opioid receptor binding and functional coupling to G proteins in the amygdala of fawn-hooded rats. J. Pharmacol. Exp. Ther. 310, 1020 1026.
16. Di Chiara G. Imperato A. (1988) Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc. Natl Acad. Sci. USA 85, 5274 5278.
17. Di Chiara G., Bassareo V., Fenu S., De Luca M. A., Spina L., Cadoni C., Acquas E., Carboni E., Valentini V. Lecca D. (2004) Dopamine and drug addiction: the nucleus accumbens shell connection. Neuropharmacology 47 (Suppl. 1 227 241.
18. Edwards S. Self D. W. (2006) Monogamy: dopamine ties the knot. Nat. Neurosci. 9, 7 8.
19. Everitt B. J. Robbins T. W. (2005) Neural systems of reinforcement for drug addiction: from actions to habits to compulsion. Nat. Neurosci. 8, 1481 1489.
20. Finkelstein D. I., Stanic D., Parish C. L., Tomas D., Dickson K. Horne M. K. (2000) Axonal sprouting following lesions of the rat substantia nigra. Neuroscience 97, 99 112.
21. Fuller R. W. (1991) Role of serotonin in therapy of depression and related disorders. J. Clin. Psychiatry 52 (Suppl. 52 57.
22. Fuller R. W. (1994) Uptake inhibitors increase extracellular serotonin concentration measured by brain microdialysis. Life Sci. 55, 163 167.
23. Fuller R. W. (1995) Serotonin uptake inhibitors: uses in clinical therapy and in laboratory research. Prog. Drug Res. 45, 167 204.
24. Georgievska B., Kirik D. Bjorklund A. (2002) Aberrant sprouting and downregulation of tyrosine hydroxylase in lesioned nigrostriatal dopamine neurons induced by long-lasting overexpression of glial cell line derived neurotrophic factor in the striatum by lentiviral gene transfer. Exp. Neurol. 177, 461 474.
25. Gerdeman G. L., Partridge J. G., Lupica C. R. Lovinger D. M. (2003) It could be habit forming: drugs of abuse and striatal synaptic plasticity. Trends Neurosci. 26, 184 192.
26. Graybiel A. M. (1990) Neurotransmitters and neuromodulators in the basal ganglia. Trends Neurosci. 13, 244 254.
27. Gundersen H. J., Bagger P., Bendtsen T. F. et al. (1988) The new stereological tools: disector, fractionator, nucleator and point sampled intercepts and their use in pathological research and diagnosis. APMIS 96, 857 881.
28. Hensler J. G. (2002) Differential regulation of 5-HT1A receptor-G protein interactions in brain following chronic antidepressant administration. Neuropsychopharmacology 26, 565 573.
29. Hersch S. M., Ciliax B. J., Gutekunst C. A., Rees H. D., Heilman C. J., Yung K. K., Bolam J. P., Ince E., Yi H. Levey A. I. (1995) Electron microscopic analysis of D1 and D2 dopamine receptor proteins in the dorsal striatum and their synaptic relationships with motor corticostriatal afferents. J. Neurosci. 15, 5222 5237.
30. Hyman S. E. Malenka R. C. (2001) Addiction and the brain: the neurobiology of compulsion and its persistence. Nat. Rev. Neurosci. 2, 695 703.
31. Kelly M. A., Rubinstein M., Asa S. L. et al. (1997) Pituitary lactotroph hyperplasia and chronic hyperprolactinemia in dopamine D2 receptor-deficient mice. Neuron 19, 103 113.
32. Kimmel H. L., Joyce A. R., Carroll F. I. Kuhar M. J. (2001) Dopamine D1 and D2 receptors influence dopamine transporter synthesis and degradation in the rat. J. Pharmacol. Exp. Ther. 298, 129 140.
33. Koob G. F. Le Moal M. (1997) Drug abuse: hedonic homeostatic dysregulation. Science 278, 52 58.
34. Koob G. F., Sanna P. P. Bloom F. E. (1998) Neuroscience of addiction. Neuron 21, 467 476.
35. Kugaya A., Seneca N. M., Snyder P. J., Williams S. A., Malison R. T., Baldwin R. M., Seibyl J. P. Innis R. B. (2003) Changes in human in vivo serotonin and dopamine transporter availabilities during chronic antidepressant administration. Neuropsychopharmacology 28, 413 420.
36. Kuhar M. J. (1992) Molecular pharmacology of cocaine: a dopamine hypothesis and its implications. Ciba Found. Symp. 166, 81 89 discussion 89-95.
37. Kuhar M. J., Ritz M. C. Boja J. W. (1991) The dopamine hypothesis of the reinforcing properties of cocaine. Trends Neurosci. 14, 299 302.
38. Lawrence A. J. Marsden C. A. (1992) Terminal autoreceptor control of 5-hydroxytryptamine release as measured by in vivo microdialysis in the conscious guinea-pig. J. Neurochem. 58, 142 146.
39. Lawrence A. J., Parish C. L., Chen F., Lodge D. J., Krstew E. V., Card K., Finkelstein D. I. Horne M. K. (2005) Chronic corticotropin-releasing factor type 1 receptor antagonism with antalarmin regulates the dopaminergic system of Fawn-Hooded rats. J. Neurochem. 94, 1523 1534.
40. Lee J., Zhu W. M., Stanic D. et al. (2008) Sprouting of dopamine terminals and altered dopamine release and uptake in Parkinsonian dyskinaesia. Brain 131, 1574 1587.
41. Lindgren N., Xu Z. Q., Herrera-Marschitz M., Haycock J., Hokfelt T. Fisone G. (2001) Dopamine D(2) receptors regulate tyrosine hydroxylase activity and phosphorylation at Ser40 in rat striatum. Eur. J. Neurosci. 13, 773 780.
42. Mateo Y., Budygin E. A., John C. E. Jones S. R. (2004) Role of serotonin in cocaine effects in mice with reduced dopamine transporter function. Proc. Natl Acad. Sci. USA 101, 372 377.
43. el Mestikawy S., Glowinski J. Hamon M. (1986) Presynaptic dopamine autoreceptors control tyrosine hydroxylase activation in depolarized striatal dopaminergic terminals. J. Neurochem. 46, 12 22.
44. Miner L. H., Schroeter S., Blakely R. D. Sesack S. R. (2000) Ultrastructural localization of the serotonin transporter in superficial and deep layers of the rat prelimbic prefrontal cortex and its spatial relationship to dopamine terminals. J. Comp. Neurol. 427, 220 234.
45. Muller C. P., Carey R. J., De Souza Silva M. A., Jocham G. Huston J. P. (2002) Cocaine increases serotonergic activity in the hippocampus and nucleus accumbens in vivo: 5-HT1a-receptor antagonism blocks behavioral but potentiates serotonergic activation. Synapse 45, 67 77.
46. Onali P., Olianas M. C. Bunse B. (1988) Evidence that adenosine A2 and dopamine autoreceptors antagonistically regulate tyrosine hydroxylase activity in rat striatal synaptosomes. Brain Res. 456, 302 309.
47. Owens M. J., Krulewicz S., Simon J. S., Sheehan D. V., Thase M. E., Carpenter D. J., Plott S. J. Nemeroff C. B. (2008) Estimates of serotonin and norepinephrine transporter inhibition in depressed patients treated with paroxetine or venlafaxine. Neuropsychopharmacology Epub ahead of print C. L., Finkelstein D. I., Drago J., Borrelli E. Horne M. K. (2001) The role of dopamine receptors in regulating the size of axonal arbors. J. Neurosci. 21, 5147 5157.
48. Parish C. L., Stanic D., Drago J., Borrelli E., Finkelstein D. I. Horne M. K. (2002) Effects of long-term treatment with dopamine receptor agonists and antagonists on terminal arbor size. Eur. J. Neurosci. 16, 787 794.
49. Parish C. L., Drago J., Stanic D., Borrelli E., Finkelstein D. I. Horne M. K. (2005) Haloperidol treatment reverses behavioural and anatomical changes in cocaine-dependent mice. Neurobiol. Dis. 19, 301 311.
50. Paterson N. E. Markou A. (2007) Animal models and treatments for addiction and depression co-morbidity. Neurotox. Res. 11, 1 32.
51. Pepper J. P., Baumann M. H., Ayestas M. Rothman R. B. (2001) Inhibition of MAO-A fails to alter cocaine-induced increases in extracellular dopamine and norepinephrine in rat nucleus accumbens. Brain Res. Mol. Brain Res. 87, 184 189.
52. Picconi B., Pisani A., Centonze D., Battaglia G., Storto M., Nicoletti F., Bernardi G. Calabresi P. (2002) Striatal metabotropic glutamate receptor function following experimental parkinsonism and chronic levodopa treatment. Brain 125, 2635 2645.
53. Picconi B., Centonze D., Hakansson K., Bernardi G., Greengard P., Fisone G., Cenci M. A. Calabresi P. (2003) Loss of bidirectional striatal synaptic plasticity in l-DOPA-induced dyskinesia. Nat. Neurosci. 6, 501 506.
54. Reynolds J. N., Hyland B. I. Wickens J. R. (2001) A cellular mechanism of reward-related learning. Nature 413, 67 70.
55. Ritz M. C. Kuhar M. J. (1989) Relationship between self-administration of amphetamine and monoamine receptors in brain: comparison with cocaine. J. Pharmacol. Exp. Ther. 248, 1010 1017.
56. Robinson M. B. (2002) Regulated trafficking of neurotransmitter transporters: common notes but different melodies. J. Neurochem. 80, 1 11.
57. Rocha B. A., Fumagalli F., Gainetdinov R. R., Jones S. R., Ator R., Giros B., Miller G. W. Caron M. G. (1998) Cocaine self-administration in dopamine-transporter knockout mice. Nat. Neurosci. 1, 132 137.
58. Rosenbaum J. F. Zajecka J. (1997) Clinical management of antidepressant discontinuation. J. Clin. Psychiatry 58 (Suppl 7 37 40.
59. Rothman K. J. (1986) Modern Epidemiology. Litle Brown and Company, Boston/Toronto.
60. Schultz W. (2002) Getting formal with dopamine and reward. Neuron 36, 241 263.
61. Self D. (2003) Neurobiology: dopamine as chicken and egg. Nature 422, 573 574.
62. Sesack S. R., Carr D. B., Omelchenko N. Pinto A. (2003) Anatomical substrates for glutamate-dopamine interactions: evidence for specificity of connections and extrasynaptic actions. Ann. NY Acad. Sci. 1003, 36 52.
63. Shen Q., Goderie S. K., Jin L., Karanth N., Sun Y., Abramova N., Vincent P., Pumiglia K. Temple S. (2004) Endothelial cells stimulate self-renewal and expand neurogenesis of neural stem cells. Science 304, 1338 1340.
64. Sora I., Hall F. S., Andrews A. M., Itokawa M., Li X. F., Wei H. B., Wichems C., Lesch K. P., Murphy D. L. Uhl G. R. (2001) Molecular mechanisms of cocaine reward: combined dopamine and serotonin transporter knockouts eliminate cocaine place preference. Proc. Natl Acad. Sci. USA 98, 5300 5305.
65. Stanic D., Finkelstein D. I., Bourke D. W., Drago J. Horne M. K. (2003a) Timecourse of striatal re-innervation following lesions of dopaminergic SNpc neurons of the rat. Eur. J. Neurosci. 18, 1175 1188.
66. Stanic D., Parish C. L., Zhu W. M., Krstew E. V., Lawrence A. J., Drago J., Finkelstein D. I. Horne M. K. (2003b) Changes in function and ultrastructure of striatal dopaminergic terminals that regenerate following partial lesions of the SNpc. J. Neurochem. 86, 329 343.
67. Starke K., Montel H. Schumann H. J. (1971) Influence of cocaine and phenoxybenzamine on noradrenaline uptake and release. Naunyn Schmiedebergs Arch. Pharmacol. 270, 210 214.
68. Tepper J. M., Nakamura S., Young S. J. Groves P. M. (1984) Autoreceptor-mediated changes in dopaminergic terminal excitability: effects of striatal drug infusions. Brain Res. 309, 317 333.
69. Thomas M. J., Beurrier C., Bonci A. Malenka R. C. (2001) Long-term depression in the nucleus accumbens: a neural correlate of behavioral sensitization to cocaine. Nat. Neurosci. 4, 1217 1223.
70. Tobler P. N., Fiorillo C. D. Schultz W. (2005) Adaptive coding of reward value by dopamine neurons. Science 307, 1642 1645.
71. Ungerstedt U., Herrera-Marschitz M., Stahle L. Zetterstrom T. (1982) Models for studying the synaptic mechanisms: correlative measurements of transmitter release and drug altered behaviour, in Behavioural Models and the Analysis of Drug Action (Spiegelstein M. Y. Levy A., eds pp. 57 70. Elsevier, Amsterdam.
72. Zhao Z., Baros A. M., Zhang H. T., Lapiz M. D., Bondi C. O., Morilak D. A. O'Donnell J. M. (2008) Norepinephrine transporter regulation mediates the long-term behavioral effects of the antidepressant desipramine. Neuropsychopharmacology Epub ahead of print L., Huang K. X., Kecojevic A., Welsh A. M. Koliatsos V. E. (2006) Evidence that serotonin reuptake modulators increase the density of serotonin innervation in the forebrain. J. Neurochem. 96, 396 406.